Functional role of ginseng-derived compounds in cancer

Journal of Ginseng Research

Volumn 42, Issue 3, 2018, Pages 248-254

  Ahuja, Akash ^a   Kim, Ji Hye ^a   Kim, Jong Hoon ^c   Yi, Young Su ^b   Cho, Jae Youl ^a  

^a Sungkyunkwan University   (South Korea)

^b Chongju University   (South Korea)

^c Chonbuk National University   (South Korea)

Author keywords

anticancer activity; ginseng derived compounds; ginsenosides; Panax ginseng

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIMETASTATIC AGENT; ANTIOXIDANT; GINSENOSIDE; GINTONIN; MICRORNA; NEUROPROTECTIVE AGENT; UNCLASSIFIED DRUG;

ALTERNATIVE MEDICINE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; CANCER PREVENTION; CANCER THERAPY; CHEMOPROPHYLAXIS; DRUG EFFECT; GENE EXPRESSION; GINSENG; HUMAN; MALIGNANT NEOPLASM; METASTASIS INHIBITION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE;

EID: 85023751094     PISSN: 12268453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgr.2017.04.009     Document Type: Review

References (99)

1. Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D., Bray, F., Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:5 (2015), E359–E386.
2. von Kitzing, E., Jonas, P., Sakmann, B., Europepmc_Citation. Res Vet Sci 30 (1994), 364–367.
3. O'Brien, T.G., Simsiman, R.C., Boutwell, R.K., Induction of the polyamine-biosynthetic enzymes in mouse epidermis by tumor-promoting agents. Cancer Res 35:7 (1975), 1662–1670.
4. Wong, A.S.T., Che, C.-M., Leung, K.-W., Karmazyn, M., Moey, M., Gan, X.T., Liu, J., Wang, S., Liu, H., Yang, L., et al. Recent advances in ginseng as cancer therapeutics: a functional and mechanistic overview. Nat Prod Rep [Internet] 32:2 (2015), 256–272 Available from: http://xlink.rsc.org/?DOI=C4NP00080C.
5. Qu, C., Bai, Y., Jin, X., Wang, Y., Zhang, K., You, J., Zhang, H., Study on ginsenosides in different parts and ages of Panax quinquefolius L. Food Chem [Internet] 115:1 (2009), 340–346, 10.1016/j.foodchem.2008.11.079 Available from:.
6. Wang, A., Wang, C.-Z., Wu, J.-A., Osinski, J., Yuan, C.-S., Determination of major ginsenosides in Panax quinquefolius (American ginseng) using high-performance liquid chromatography. Phytochem Anal 16:4 (2005), 272–277.
7. Nag, S.A., Ginsenosides as anticancer agents: in vitro and in vivo activities, structure–activity relationships, and molecular mechanisms of action. Front Pharmacol [Internet], 3, 2012 February, 25 Available from: http://www.ncbi.nlm.nih.gov/pubmed/22403544.
8. Sun, B.-S., Gu, L.-J., Fang, Z.-M., Wang, C., Wang, Z., Lee, M.-R., Li, Z., Li, J.-J., Sung, C.-K., Simultaneous quantification of 19 ginsenosides in black ginseng developed from Panax ginseng by HPLC-ELSD. J Pharm Biomed Anal 50:1 (2009 Aug), 15–22.
9. Xie, Y.Y., Luo, D., Cheng, Y.J., Ma, J.F., Wang, Y.M., Liang, Q.L., Luo, G.A., Steaming-induced chemical transformations and holistic quality assessment of red ginseng derived from Panax ginseng by means of HPLC-ESI-MS/MS n-based multicomponent quantification fingerprint. J Agric Food Chem 60:33 (2012), 8213–8224.
10. Pyo, M.K., Choi, S.-H., Hwang, S.H., Shin, T.-J., Lee, B.-H., Lee, S.-M., Lim, Y.-H., Kim, D.-H., Nah, S.-Y., Novel glycolipoproteins from ginseng. J Ginseng Res 35:1 (2011), 92–103.
11. Hwang, S.H., Shin, T.J., Choi, S.H., Cho, H.J., Lee, B.H., Pyo, M.K., Lee, J.H., Kang, J., Kim, H.J., Park, C.W., et al. Gintonin, newly identified compounds from ginseng, is novel lysophosphatidic acids-protein complexes and activates G protein-coupled lysophosphatidic acid receptors with high affinity. Mol Cells 33:2 (2012), 151–162.
12. Chun, J., Hla, T., Lynch, K.R., Spiegel, S., Moolenaar, W.H., International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid. Pharmacol Rev 62:4 (2010), 579–587.
13. Karmazyn, M., Moey, M., Gan, X.T., Therapeutic potential of ginseng in the management of cardiovascular disorders. Drugs 71:15 (2011 Oct), 1989–2008.
14. Liu, J., Wang, S., Liu, H., Yang, L., Nan, G., Stimulatory effect of saponin from Panax ginseng on immune function of lymphocytes in the elderly. Mech Ageing Dev 83 (1995), 43–53.
15. Rai, D., Bhatia, G., Sen, T., Palit, G., Anti-stress effects of Ginkgo biloba and Panax ginseng: a comparative study. J Pharmacol Sci [Internet] 93:4 (2003), 458–464 Available from: http://www.ncbi.nlm.nih.gov/pubmed/14737017.
16. Oliynyk, S., Oh, S., Actoprotective effect of ginseng: improving mental and physical performance. J Ginseng Res 37:2 (2013), 144–166.
17. Zhao, R., McDaniel, W.F., Ginseng improves strategic learning by normal and brain-damaged rats. Neuroreport 9:7 (1998 May), 1619–1624.
18. Coleman, C.I., Hebert, J.H., Reddy, P., Effects of Panax ginseng on stress. J Ginseng Res 32:1 (2008), 8–14.
19. Reay, J.L., Scholey, A.B., Kennedy, D.O., Panax ginseng (G115) improves aspects of working memory performance and subjective ratings of calmness in healthy young adults. Hum Psychopharmacol 25:6 (2010 Aug), 462–471.
20. Shin, H.R., Kim, J.Y., Yun, T.K., Morgan, G., Vainio, H., The cancer-preventive potential of Panax ginseng: a review of human and experimental evidence. Cancer Causes Control [Internet] 11:6 (2000), 565–576 Available from: http://www.ncbi.nlm.nih.gov/pubmed/10880039.
21. Lu, H., Ouyang, W., Huang, C., Inflammation, a key event in cancer development. Mol Cancer Res 4:4 (2006), 221–233.
22. Bartel, D.P., MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:2 (2004), 281–297.
23. Kim, V.N., Nam, J.W., Genomics of microRNA. Trends Genet 22 (2006), 165–173.
24. Fiorucci, G., Chiantore, M.V., Mangino, G., Percario, Z.A., Affabris, E., Romeo, G., Cancer regulator MICRORNA: potential relevance in diagnosis, prognosis and treatment of cancer [Internet]. Curr Med Chem 19 (2012), 461–474 Available from: http://www.eurekaselect.com/node/76151/article.
25. Chan, L.S., Yue, P.Y.K., Mak, N.K., Wong, R.N.S., Role of MICRORNA-214 in ginsenoside-Rg1-induced angiogenesis. Eur J Pharm Sci 38:4 (2009), 370–377.
26. Chan, L.S., Yue, P.Y.K., Wong, Y.Y., Wong, R.N.S., MicroRNA-15b contributes to ginsenoside-Rg1-induced angiogenesis through increased expression of VEGFR-2. Biochem Pharmacol 86:3 (2013), 392–400.
27. Baeg, I.H., So, S.H., The world ginseng market and the ginseng (Korea). J Ginseng Res 37 (2013), 1–7.
28. Hussain, S.P., Hofseth, L.J., Harris, C.C., Radical causes of cancer. Nat Rev Cancer 3:4 (2003), 276–285.
29. Coussens, L.M., Werb, Z., Inflammation and cancer. Nature 420:6917 (2002), 860–867.
30. Demaria, S., Pikarsky, E., Karin, M., Coussens, L.M., Chen, Y.-C., El-Omar, E.M., Trinchieri, G., Dubinett, S.M., Mao, J.T., Sazbo, E., et al. Cancer and inflammation: promise for biologic therapy. J Immunother 33:4 (2010), 335–351.
31. Coussens, L.M., Zitvogel, L., Palucka, A.K., Neutralizing tumor-promoting chronic inflammation: a magic bullet?. Science [Internet] 339:6117 (2013), 286–291 Available from: http://www.ncbi.nlm.nih.gov/pubmed/23329041%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC3591506.
32. Kim, Y.J., Chung, J.W., Lee, S.J., Choi, K.S., Kim, J.H., Hahm, K.B., Progression from chronic atrophic gastritis to gastric cancer; tangle, toggle, tackle with Korea red ginseng. J Clin Biochem Nutr 46:3 (2010), 195–204.
33. Jung, J.H., Kang, I.G., Kim, D.Y., Hwang, Y.J., Kim, S.T., The effect of Korean red ginseng on allergic inflammation in a murine model of allergic rhinitis. J Ginseng Res 37:2 (2013), 167–175.
34. Hong, C.-E., Lyu, S.-Y., Anti-inflammatory and anti-oxidative effects of Korean red ginseng extract in human keratinocytes. Immune Netw 11 (2011), 42–49.
35. Yang, Y., Yang, W.S., Yu, T., Sung, G.H., Park, K.W., Yoon, K., Son, Y.J., Hwang, H., Kwak, Y.S., Lee, C.M., et al. ATF-2/CREB/IRF-3-targeted anti-inflammatory activity of Korean red ginseng water extract. J Ethnopharmacol 154:1 (2014), 218–228.
36. Park, J.G., Kang, W.S., Park, K.T., Park, D.J., Aravinthan, A., Kim, J.H., Cho, J.Y., Anticancer effect of joboksansam, Korean wild ginseng germinated from bird feces. J Ginseng Res 40:3 (2016), 304–308.
37. Kim, H.S., Lim, J.M., Kim, J.Y., Kim, Y., Park, S., Sohn, J., Panaxydol, a component of Panax ginseng, induces apoptosis in cancer cells through EGFR activation and ER stress and inhibits tumor growth in mouse models. Int J Cancer 138:6 (2016), 1432–1441.
38. Choi, K., Choi, C., Proapoptotic ginsenosides compound K and Rh2 enhance Fas-induced cell death of human astrocytoma cells through distinct apoptotic signaling pathways. Cancer Res Treat 41:1 (2009), 36–44.
39. Kim, M.-Y., Yoo, B.C., Cho, J.Y., Ginsenoside-Rp1-induced apolipoprotein A-1 expression in the LoVo human colon cancer cell line. J Ginseng Res [Internet] 38:4 (2014), 251–255 Available from: http://www.sciencedirect.com/science/article/pii/S1226845314000694.
40. Mao, Q., Zhang, P.-H., Wang, Q., Li, S.-L., Ginsenoside F2 induces apoptosis in humor gastric carcinoma cells through reactive oxygen species-mitochondria pathway and modulation of ASK-1/JNK signaling cascade in vitro and in vivo. Phytomedicine 21:4 (2014), 515–522.
41. Wang, J.-H., Nao, J.-F., Zhang, M., He, P., 20(s)-Ginsenoside Rg3 promotes apoptosis in human ovarian cancer HO-8910 cells through PI3K/Akt and XIAP pathways. Tumor Biol [Internet] 35:12 (2014), 11985–11994, 10.1007/s13277-014-2497-5 Available from:.
42. Zhao, Q., Zheng, X., Jiang, J., Zhou, H., Hu, P., Determination of ginsenoside Rg3 in human plasma and urine by high performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 878:24 (2010), 2266–2273.
43. Kim, Y.J., Choi, W.I., Jeon, B.N., Choi, K.C., Kim, K., Kim, T.J., Ham, J., Jang, H.J., Kang, K.S., Ko, H., et al. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance. Toxicology 322 (2014), 23–33.
44. Yoo, H.H., Yokozawa, T., Satoh, A., Kang, K.S., Kim, H.Y., Effects of ginseng on the proliferation of human lung fibroblasts. Am J Chin Med 34:1 (2006), 137–146.
45. Liu, T.-G.G., Huang, Y., Cui, D.-D.D., Huang, X.-B.B., Mao, S.-H.H., Ji, L.-L.L., Song, H.-B., Yi, C., Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice. BMC Cancer, 9(250), 2009, 250.
46. Lee, Y.J., Lee, S., Ho, J.N., Byun, S.S., Hong, S.K., Lee, S.E., Lee, E., Synergistic antitumor effect of ginsenoside Rg3 and cisplatin in cisplatin-resistant bladder tumor cell line. Oncol Rep 32:5 (2014), 1803–1808.
47. Mochizuki, M., Yoo, Y.C., Matsuzawa, K., Sato, K., Saiki, I., Tono-oka, S., Samukawa, K., Azuma, I., Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng. Biol Pharm Bull [Internet] 18:9 (1995), 1197–1202.
48. Liu, T., Zhao, L., Zhang, Y., Chen, W., Liu, D., Hou, H., Ding, L., Li, X., Ginsenoside 20(S)-Rg3 targets HIF-1α to Block hypoxia-induced epithelial-mesenchymal transition in ovarian cancer cells. PLoS One 9:9 (2014), 1–12.
49. Zhang, F., Li, M., Wu, X., Hu, Y., Cao, Y., Wang, W., Xiang, S., Li, H., Jiang, L., Tan, Z., et al. 20 (S)-ginsenoside Rg3 promotes senescence and apoptosis in gallbladder cancer cells via the p53 pathway. Drug Des Devel Ther 9 (2015), 3969–3987.
50. Xia, T., Wang, J.-C., Xu, W., Xu, L.-H., Lao, C.-H., Ye, Q.-X., Fang, J.P., 20(S)-Ginsenoside Rh2 induces apoptosis in human leukaemia Reh cells through mitochondrial signaling pathways. Biol Pharm Bull [Internet] 37:2 (2014), 248–254 Available from: http://www.ncbi.nlm.nih.gov/pubmed/24492721.
51. Bi, W.Y., Fu, B.D., Shen, H.Q., Wei, Q., Zhang, C., Song, Z., Qin, Q.Q., Li, H.P., Lv, S., Wu, S.C., et al. Sulfated derivative of 20(S)-Ginsenoside Rh2 inhibits inflammatory cytokines through MAPKs and NF-kappa B pathways in LPS-Induced RAW264.7 macrophages. Inflammation 35:5 (2012), 1659–1668.
52. Ko, H., Kim, Y.J., Park, J.S., Park, J.H., Yang, H.O., Autophagy inhibition enhances apoptosis induced by ginsenoside Rk1 in hepatocellular carcinoma cells. Biosci Biotechnol Biochem 73:10 (2009), 2183–2189.
53. Zhang, Y.X., Wang, L., Xiao, E.L., Li, S.J., Chen, J.J., Gao, B., Min, G.N., Wang, Z.P., Wu, Y.J., Ginsenoside-Rd exhibits anti-inflammatory activities through elevation of antioxidant enzyme activities and inhibition of JNK and ERK activation in vivo. Int Immunopharmacol 17:4 (2013), 1094–1100.
54. Li, L., Wang, Y., Qi, B., Yuan, D., Dong, S., Suppression of PMA-induced tumor cell invasion and migration by ginsenoside Rg1 via the inhibition of NF- κ B-dependent MMP-9 expression. Ontol Reports 32 (2014), 1779–1786.
55. Lin, Y., Jiang, D., Li, Y., Han, X., Yu, D., Park, J.H., Jin, Y.H., Effect of sun ginseng potentiation on epirubicin and paclitaxel-induced apoptosis in human cervical cancer cells. J Ginseng Res 39:1 (2015), 22–28.
56. Lee, J.I., Ha, Y.W., Choi, T.W., Kim, H.J., Kim, S.M., Jang, H.J., Choi, J.H., Choi, M.H., Chung, B.C., Sethi, G., et al. Cellular uptake of ginsenosides in Korean white ginseng and red ginseng and their apoptotic activities in human breast cancer cells. Planta Med 77:2 (2011), 133–140.
57. Xu, F., Shang, W., Yu, J., Sun, Q., Li, M., Sun, J., The antitumor activity study of ginsenosides and metabolites in lung cancer cell. Am J Transl Res 8:4 (2016), 1708–1718.
58. Kim, M.J., Yun, H., Kim, D.H., Kang, I., Choe, W., Kim, S.S., Ha, J., Amp-activated protein kinase deter mines apoptotic sensitivity of cancer cells to ginsenoside-Rh2. J Ginseng Res [Internet] 38:1 (2014), 16–21, 10.1016/j.jgr.2013.11.010 Available from:.
59. Shi, Q., Li, J., Feng, Z., Zhao, L., Luo, L., You, Z., Li, D., Xia, J., Zuo, G., Chen, D., et al. Effect of ginsenoside Rh2 on the migratory ability of HepG2 liver carcinoma cells: recruiting histone deacetylase and inhibiting activator protein 1 transcription factors. Mol Med Rep 10:4 (2014), 1779–1785.
60. Dong, G., Jang, E.J., Kang, S.H., Cho, I.J., Park, S., Kim, S.C., Kim, Y.W., Red ginseng abrogates oxidative stress via mitochondria protection mediated by LKB1-AMPK pathway. BMC Complement Altern Med, 13, 2013, 64, 10.1186/1472-6882-13-64.
61. Hwang, J.A., Hwang, M.K., Jang, Y., Lee, E.J., Kim, J.E., Oh, M.H., Shin, D.J., Lim, S., Ji, G., Bode, A.M., et al. 20-O-b-d-glucopyranosyl-20(S)-protopanaxadiol, a metabolite of ginseng, inhibits colon cancer growth by targeting TRPC channel-mediated calcium influx. J Nutr Biochem 24:6 (2013), 1096–1104.
62. Yuan, H.D., Quan, H.Y., Zhang, Y., Kim, S.H., Chung, S.H., 20(S)-Ginsenoside Rg3-induced apoptosis in HT-29 colon cancer cells is associated with AMPK signaling pathway. Mol Med Rep 3:5 (2010), 825–831.
63. Kim, D.Y., Park, M.W., Yuan, H.D., Lee, H.J., Kim, S.H., Chung, S.H., Compound K induces apoptosis via CAMK-IV/AMPK pathways in HT-29 colon cancer cells. J Agric Food Chem 57:22 (2009), 10573–10578.
64. Garbe, C., Leiter, U., Epidemiology of melanoma and nonmelanoma skin cancer-the role of sunlight. Adv Exp Med Biol 624 (2008), 89–103.
65. Xiaoguang, C., Hongyan, L., Xiaohong, L., Zhaodi, F., Yan, L., Lihua, T., Rui, H., Cancer chemopreventive and therapeutic activities of red ginseng. J Ethnopharmacol 60:1 (1998), 71–78.
66. Sharma, J., Goyal, P.K., Chemoprevention of chemical-induced skin cancer by Panax ginseng root extract. J Ginseng Res [Internet] 39:3 (2015), 265–273, 10.1016/j.jgr.2015.01.005 Available from:.
67. Kumar, A., Kumar, M., Panwar, M., Samarth, R.M., Park, T.Y., Park, M.H., Kimura, H., Evaluation of chemopreventive action of Ginsenoside Rp1. Biofactors 26 (2006), 29–43.
68. Choi, C.H., Kang, G., Min, Y.D., Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng. Planta Med 69:3 (2003), 235–240.
69. Kim, S.W., Kwon, H.Y., Chi, D.W., Shim, J.H., Park, J.D., Lee, Y.H., Pyo, S., Rhee, D.K., Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg3. Biochem Pharmacol 65:1 (2003), 75–82.
70. Li, N., Wang, D., Ge, G., Wang, X., Liu, Y., Yang, L., Ginsenoside metabolites inhibit P-glycoprotein in vitro and in situ using three absorption models. Planta Med 80:4 (2014), 290–296.
71. Yuan, C.S., Wei, G., Dey, L., Karrison, T., Nahlik, L., Maleckar, S., Kasza, K., Ang-Lee, M., Moss, J., Brief communication: American ginseng reduces warfarin's effect in healthy patients. A randomized, controlled trial. Ann Intern Med 141:1 (2004), 23–27.
72. Jung, C.H., Seog, H.M., Choi, I.W., Park, M.W., Cho, H.Y., Antioxidant properties of various solvent extracts from wild ginseng leaves. LWT – Food Sci Technol 39:3 (2006), 266–274.
73. Pan, H.Y., Qu, Y., Zhang, J.K., Kang, T.G., Dou, D.Q., Antioxidant activity of ginseng cultivated under mountainous forest with different growing years. J Ginseng Res 37:3 (2013), 355–360.
74. Wei, X., Su, F., Su, X., Hu, T., Hu, S., Stereospecific antioxidant effects of ginsenoside Rg3 on oxidative stress induced by cyclophosphamide in mice. Fitoterapia 83:4 (2012), 636–642.
75. Lü, J.-M., Weakley, S.M., Yang, Z., Hu, M., Yao, Q., Chen, C., Ginsenoside Rb1 directly scavenges hydroxyl radical and hypochlorous acid. Curr Pharma Des 18 (2012), 6339–6347.
76. Lo, Y.-T., Tsai, Y.-H., Wu, S.-J., Chen, J.-R., Chao, J.C.-J., Ginsenoside Rb1 inhibits cell activation and liver fibrosis in rat hepatic stellate cells. J Med Food 14:10 (2011), 1135–1143.
77. Liu, Q., Kou, J.P., Yu, B.Y., Ginsenoside Rg1 protects against hydrogen peroxide-induced cell death in PC12 cells via inhibiting NF-κB activation. Neurochem Int 58:1 (2011), 119–125.
78. Kwok, H.H., Ng, W.Y., Yang, M.S.M., Mak, N.K., Wong, R.N.S., Yue, P.Y.K., The ginsenoside protopanaxatriol protects endothelial cells from hydrogen peroxide-induced cell injury and cell death by modulating intracellular redox status. Free Radic Biol Med 48:3 (2010), 437–445.
79. Lee, L.S., Wise, S.D., Chan, C., Parsons, T.L., Flexner, C., Lietman, P.S., Possible differential induction of phase 2 enzyme and antioxidant pathways by american ginseng, Panax quinquefolius. J Clin Pharmacol 48:5 (2008), 599–609.
80. Saw, C.L.L., Yang, A.Y., Cheng, D.C., Boyanapalli, S.S.S., Su, Z.Y., Khor, T.O., Gao, S., Wang, J., Jiang, Z.H., Tony Kong, A.N., et al. Pharmacodynamics of ginsenosides: antioxidant activities, activation of Nrf2, and potential synergistic effects of combinations. Chem Res Toxicol 25:8 (2012), 1574–1580.
81. Bak, M.-J., Jun, M., Jeong, W.-S., Antioxidant and hepatoprotective effects of the red ginseng essential oil in H(2)O(2)-treated hepG2 cells and CCl(4)-treated mice. Int J Mol Sci 13:2 (2012), 2314–2330.
82. Chae, S., Kang, K.A., Chang, W.Y., Kim, M.J., Lee, S.J., Lee, Y.S., Kim, H.S., Kim, D.H., Hyun, J.W., Effect of compound K, a metabolite of ginseng saponin, combined with gamma-ray radiation in human lung cancer cells in vitro and in vivo. J Agric Food Chem 57:13 (2009), 5777–5782.
83. Kim, A.D., Kang, K.A., Kim, H.S., Kim, D.H., Choi, Y.H., Lee, S.J., Kim, H.S., Hyun, J.W., A ginseng metabolite, compound K, induces autophagy and apoptosis via generation of reactive oxygen species and activation of JNK in human colon cancer cells. Cell Death Dis, 4, 2013, e750.
84. Wang, P., Cui, J., Du, X., Yang, Q., Jia, C., Xiong, M., Yu, X., Li, L., Wang, W., Chen, Y., et al. Panax notoginseng saponins (PNS) inhibits breast cancer metastasis. J Ethnopharmacol 154:3 (2014), 663–671.
85. Yang, Q., Wang, X., Cui, J., Wang, P., Xiong, M., Jia, C., Lui, L., Ning, B., Li, L., Wang, W., et al. Bidirectional regulation of angiogenesis and miR-18a expression by PNS in the mouse model of tumor complicated by myocardial ischemia. BMC Complement Altern Med, 14, 2014, 183.
86. Zhang, X., Shi, M., Ye, R., Wang, W., Liu, X., Zhang, G., Han, J., Zhang, Y., Wang, B., Zhao, J., et al. Ginsenoside Rd attenuates tau protein phosphorylation via the PI3K/AKT/GSK-3b pathway after transient forebrain ischemia. Neurochem Res 39:7 (2014), 1363–1373.
87. Zeng, X., Li, J., Li, Z., Ginsenoside Rd mitigates myocardial ischemia-reperfusion injury via Nrf2/HO-1 signaling pathway. Int J Clin Exp Med 8:8 (2015), 14497–14504.
88. Yoon, J.H., Choi, Y.J., Cha, S.W., Lee, S.G., Anti-metastatic effects of ginsenoside Rd via inactivation of MAPK signaling and induction of focal adhesion formation. Phytomedicine 19:3–4 (2012), 284–292.
89. Wang, P., Du, X., Xiong, M., Cui, J., Yang, Q., Wang, W., Chen, Y., Zhang, T., Ginsenoside Rd attenuates breast cancer metastasis implicating derepressing microRNA-18a-regulated Smad2 expression. Sci Rep [Internet], 6, 2016 March, 33709 Available from: http://www.nature.com/articles/srep33709.
90. Wu, N., Wu, G., Hu, R., Li, M., Feng, H., Ginsenoside Rh2 inhibits glioma cell proliferation by targeting microRNA-128. Acta Pharmacol Sin 32:3 (2011), 345–353.
91. Jiao, X., Zhao, L., Ma, M., Bai, X., He, M., Yan, Y., Wang, Y., Chen, Q., Zhao, X., Zhou, M., et al. MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2). Breast Cancer Res Treat 139:3 (2013), 717–730.
92. Wen, X., Zhang, H.Da, Zhao, L., Yao, Y.F., Zhao, J.H., Tang, J.H., Ginsenoside Rh2 differentially mediates microRNA expression to prevent chemoresistance of breast cancer. Asian Pacific J Cancer Prev 16:3 (2015), 1105–1109.
93. Keung, M.-H., Chan, L.-S., Kwok, H.-H., Wong, R.N.-S., Yue, P.Y.-K., Role of microRNA-520h in 20(R)-ginsenoside-Rg3-mediated angiosuppression. J Ginseng Res 40:2 (2016), 151–159.
94. Zeng, D., Wang, J., Kong, P., Chang, C., Li, J., Li, J., Ginsenoside Rg3 inhibits HIF-1α and VEGF expression in patient with acute leukemia via inhibiting the activation of PI3K/Akt and ERK1/2 pathways. Int J Clin Exp Pathol 7:5 (2014), 2172–2178.
95. Nah, S.Y., Ginseng ginsenoside pharmacology in the nervous system: involvement in the regulation of ion channels and receptors. Front Physiol 5 (2014 March), 1–13.
96. Kim, S., Kim, M.S., Park, K., Kim, H.J., Jung, S.W., Nah, S.-Y., Han, J.S., Chung, C.H., Hippocampus-dependent cognitive enhancement induced by systemic gintonin administration. J Ginseng Res 40:1 (2016), 55–61.
97. Park, H., Kim, S., Rhee, J., Kim, H.-J., Han, J.-S., Nah, S.-Y., Chung, C.H., Synaptic enhancement induced by gintonin via lysophosphatidic acid receptor activation in central synapses. J Neurophysiol 113:5 (2015), 1493–1500.
98. Hwang, S.H., Lee, B.H., Kim, H.J., Cho, H.J., Shin, H.C., Im, K.S., Choi, S.H., Shin, T.J., Lee, S.M., Nam, S.W., et al. Suppression of metastasis of intravenously-inoculated B16/F10 melanoma cells by the novel ginseng-derived ingredient, gintonin: involvement of autotaxin inhibition. Int J Oncol 42:1 (2013), 317–326.
99. Hwang, S.H., Shin, E.J., Shin, T.J., Lee, B.H., Choi, S.H., Kang, J., Kim, H.-J., Kwon, S.-H., Jang, C.-H., Lee, J.-H., et al. Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates alzheimer's disease-related neuropathies: involvement of non-amyloidogenic processing. J Alzheimer's Dis 31:1 (2012), 207–223.